Magnetic resonance imaging had been explored as a potential alternative to computed tomography but the majority of prior MRI nodule studies was performed with 1.5-T scanners and not with the most up to date sequences. Our study demonstrated that biomarkers derived from state of the art 3T MRI sequences can distinguish benign from malignant pulmonary nodules and correlate with morphologic and physiologic values derived from commonly used noninvasive imaging modalities.
This abstract and the presentation materials are available to members only; a login is required.